✦ LIBER ✦

Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy

✍ Scribed by Sara Boccalini; Chiara Azzari; Massimo Resti; Claudia Valleriani; Martina Cortimiglia; Emilia Tiscione; Angela Bechini; Paolo Bonanni

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN35 CLINICAL AND ECONOMIC BENEFITS OF

✍ Papanicolaou, S; Kontodimas, S; Syriopoulou, V; Tsolia, M; Theodoridou, M; Strut 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Safety and immunogenicity of the 23-vale

✍ F.M. Russell; P.V. Licciardi; A. Balloch; V. Biaukula; L. Tikoduadua; J.R. Carap 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 418 KB

Immunogenicity and safety of a 13-valent

✍ E. Grimprel; F. Laudat; S. Patterson; S.A. Baker; M.S. Sidhu; W.C. Gruber; E.A. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 195 KB

The effect of an alternative reduced-dos

✍ Ron Dagan; Noga Givon-Lavi; Nurith Porat; David Greenberg 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 631 KB

Hospitalized children with pneumonia in

✍ María Hortal; Miguel Estevan; Hilda Laurani; Inés Iraola; Miguel Meny 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 189 KB

PIN7 BUDGET IMPACT MODEL FOR CATCH-UP PR

✍ J Picazo; A Gil de Miguel; C Mendez; P Guijarro; L Garcia 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB